TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.00700nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.0180nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.0500nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.0650nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.0750nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.147nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.175nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.190nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.200nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 0.25nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 15nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
Affinity DataKi: 52nMAssay Description:Compound was evaluated for time-dependent inactivation of Ribonucleotide diphosphate reductase (RDPR) in E. coliMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 75nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 374nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 480nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 505nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 670nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 700nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 800nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity against Opioid receptor mu 1 using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity against opioid receptor mu using [3H]-etorphine as a radioligandMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 1.10E+3nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 1.20E+3nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: >1.20E+3nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: 1.50E+3nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: >2.00E+3nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Pharmacia And Upjohn
Curated by ChEMBL
Pharmacia And Upjohn
Curated by ChEMBL
Affinity DataKi: >2.00E+3nMAssay Description:Binding affinity of the compound towards HIV protease was determinedMore data for this Ligand-Target Pair
Affinity DataIC50: 5.20nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 5.40nMAssay Description:Binding affinity against Opioid receptor kappa 1 using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 7.30nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 29nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 85nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 145nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 368nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Binding affinity against opioid receptor kappa using [3H]U-69,593 as a radioligandMore data for this Ligand-Target Pair